President Joe Biden made a campaign promise to limit big pharma’s price increases on prescription drugs to no more than inflation—and now is the time to make good on that promise. A new study found that half of all Part D-covered drugs had list price increases above inflation between 2018 and 2019, and the median list price was rose 6.4%, or 3.5x the rate of inflation. List prices increased by 10% or more for 14% of all Part D-covered drugs during the same time period. Another 36% had price increases above the price of inflation but below 10%. Enough is enough!
